KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.

Nat Commun · 2026-Mar-14 · PMID 41826281

Panel B质量警告待 EXE 对齐验证

Progression-free Survival

Fig. 7. Progression-free survival by age. Kaplan–Meier estimate in subgroups aged 65 years ( A ) and ≥65 years ( B ), and subgroup analysis ( C ). Source data are provided as a Source data file.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.50
质量通过否
预期曲线2
实际曲线1
X 范围0 – 30
Y 范围0 – 100

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 22 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.98400.000098.395710225
120.13290.98403.986998.395716325
130.13510.98404.052398.395716425
140.13730.98404.117698.395716525
150.13940.97864.183097.861016626
160.14160.97864.248497.861016726
170.14380.97864.313797.861016826
180.14600.95194.379195.187216931
190.14810.95194.444495.187217031
1100.15030.95194.509895.187217131
1110.15250.95194.575295.187217231
1120.15470.95194.640595.187217331
1130.15690.95194.705995.187217431
1140.15900.95194.771295.187217531
1150.16120.95194.836695.187217631
1160.16340.94124.902094.117617733
1170.16560.92514.967392.513417836
1180.16780.92515.032792.513417936
1190.16990.92515.098092.513418036
1200.17210.92515.163492.513418136
1210.17430.92515.228892.513418236
1220.17650.92515.294192.513418336
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-24T15:13:31+00:00